Free tool
FAERS Monitor: Zurnai (Autoinjector)
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 218590 or its brand name (Zurnai (Autoinjector), Nalmefene Hydrochloride). Reports on generic versions are filed under their own applications.
Reports
32
Serious
29
91% of reports
Hospitalization
14
Death reported
6
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- coma5
- bradycardia4
- bradypnoea4
- electrocardiogram qt prolonged4
- hypothermia4
- intentional overdose4
- miosis4
- diabetic ketoacidosis3
- pneumonia aspiration3
- pulmonary oedema3
- sudden death3
- bipolar i disorder2
- blood glucose abnormal2
- blood pressure decreased2
- diarrhoea2
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 1 |
| 2005 | 3 |
| 2010 | 3 |
| 2013 | 1 |
| 2014 | 3 |
| 2015 | 1 |
| 2017 | 1 |
| 2018 | 5 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 3 |
| 2025 | 4 |
| 2026 | 4 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,054,127 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| bradypnoeaSignal | 4 | 975.8 | 389.9 | 2,977 |
| bipolar i disorder | 2 | 599.8 | 156.6 | 671 |
| miosisSignal | 4 | 327.7 | 131.0 | 997 |
| hypothermiaSignal | 4 | 259.8 | 103.9 | 789 |
| sudden deathSignal | 3 | 186.4 | 63.5 | 383 |
| diabetic ketoacidosisSignal | 3 | 82.1 | 28.0 | 166 |
| pneumonia aspirationSignal | 3 | 78.9 | 26.9 | 160 |
| electrocardiogram qt prolongedSignal | 4 | 73.1 | 29.2 | 217 |
| blood glucose abnormal | 2 | 71.2 | 18.6 | 77 |
| comaSignal | 5 | 69.0 | 30.9 | 271 |
| bradycardiaSignal | 4 | 49.6 | 19.8 | 145 |
| pulmonary oedemaSignal | 3 | 44.0 | 15.0 | 87 |
| intentional overdoseSignal | 4 | 41.0 | 16.4 | 119 |
| blood pressure decreased | 2 | 19.8 | 5.2 | 19 |
| diarrhoea | 2 | 2.0 | 0.5 | 0 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.